Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Express Scripts
Federal Trade Commission
Covington
US Department of Justice

Generated: June 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Antares Pharma Inc. v. Medac Pharma Inc. (D. Del. 2014)

« Back to Dashboard

Antares Pharma Inc. v. Medac Pharma Inc. (D. Del. 2014)

Docket ➤ Sign Up Date Filed 2014-02-28
Court District Court, D. Delaware Date Terminated 2015-04-17
Cause 35:145 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand Defendant Referred To
Parties ANTARES PHARMA INC.; BECTON DICKINSON FRANCE S.A.S.; BECTON, DICKINSON AND COMPANY; MEDAC GMBH; MEDAC PHARMA INC.
Patents 7,776,015; 8,480,631
Attorneys Ethan Haller Townsend; Imron T. Aly; Jack B. Blumenfeld; Joel M. Wallace; John C. Phillips , Jr.; Kevin E. Warner; Maryellen Noreika; Megan C. Haney
Firms Morris, Nichols, Arsht & Tunnell; Phillips, Goldman & Spence, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Antares Pharma Inc. v. Medac Pharma Inc.
The small molecule drug covered by the patents cited in this case is ➤ Sign Up .

Details for Antares Pharma Inc. v. Medac Pharma Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-02-28 1 Antares' United States Patent Nos. 8,480,631 ("the '631 patent") and 6,565,553 ("…quot;) issued U.S. Patent No. 8,480,631 on July 9, 2013. A copy of the '631 patent is attached as Exhibit… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… THE PATENTS-IN-SUIT 19. The United States Patent and Trademark Office (…the '631 patent and lawfully owns all right, title, and interest in the '631 Patent, including External link to document
2014-04-18 28 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,480,631; 6,565,553; RE 44,846…2014 17 April 2015 1:14-cv-00270 830 Patent Defendant District Court, D. External link to document
2014-02-28 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,480,631; 6,565,553. (rwc) (…2014 17 April 2015 1:14-cv-00270 830 Patent Defendant District Court, D. External link to document
2014-07-10 80 reissue of U.S. Patent No. 7,776,015 ("the '015 patent"), which issued on August 17, 2010 …based on the column and line numbers of U.S. Patent No. 7,776,015, the basis of the current reissue application…#39;847 patent") (collectively with the '553 and '631 patents, "the patents-in-suit…Brennen (U.S. Patent 4,222,392), Baum (U.S. Patent 4,929,238), Kramer (U.S. Patent 5, 176,643) and…alleging infringement of U.S. Patent Nos. 6,565,553 ("the '553 patent") and 8,480,631 (" External link to document
2015-04-17 89 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,480,631; 6,565,553, RE 44,846…2014 17 April 2015 1:14-cv-00270 830 Patent Defendant District Court, D. External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Medtronic
Harvard Business School
Federal Trade Commission
Mallinckrodt
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.